VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q130570394 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000106.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q130570394‏
035 ‎‡a (OCoLC)Q130570394‏
100 0 ‎‡a George Morris‏ ‎‡9 eo‏ ‎‡9 co‏ ‎‡9 io‏ ‎‡9 af‏ ‎‡9 vmf‏ ‎‡9 vi‏ ‎‡9 ca‏ ‎‡9 it‏ ‎‡9 an‏ ‎‡9 eu‏ ‎‡9 cy‏ ‎‡9 gd‏ ‎‡9 pt-br‏ ‎‡9 ga‏ ‎‡9 zu‏ ‎‡9 cs‏ ‎‡9 et‏ ‎‡9 gl‏ ‎‡9 ie‏ ‎‡9 id‏ ‎‡9 es‏ ‎‡9 en-gb‏ ‎‡9 lb‏ ‎‡9 wa‏ ‎‡9 nn‏ ‎‡9 min‏ ‎‡9 nb‏ ‎‡9 pms‏ ‎‡9 tr‏ ‎‡9 nap‏ ‎‡9 lij‏ ‎‡9 li‏ ‎‡9 wo‏ ‎‡9 lt‏ ‎‡9 frp‏ ‎‡9 nds-nl‏ ‎‡9 br‏ ‎‡9 rm‏ ‎‡9 ro‏ ‎‡9 ia‏ ‎‡9 sr-el‏ ‎‡9 pcd‏ ‎‡9 vec‏ ‎‡9 kab‏ ‎‡9 sco‏ ‎‡9 nrm‏ ‎‡9 ast‏ ‎‡9 hr‏ ‎‡9 bm‏ ‎‡9 de‏ ‎‡9 hu‏ ‎‡9 rgn‏ ‎‡9 da‏ ‎‡9 fr‏ ‎‡9 prg‏ ‎‡9 mi‏ ‎‡9 fi‏ ‎‡9 vls‏ ‎‡9 vo‏ ‎‡9 kg‏ ‎‡9 en-ca‏ ‎‡9 scn‏ ‎‡9 jam‏ ‎‡9 mg‏ ‎‡9 bar‏ ‎‡9 pt‏ ‎‡9 gsw‏ ‎‡9 sc‏ ‎‡9 fur‏ ‎‡9 sw‏ ‎‡9 sv‏ ‎‡9 de-ch‏ ‎‡9 frc‏ ‎‡9 sk‏ ‎‡9 pap‏ ‎‡9 oc‏ ‎‡9 ms‏ ‎‡9 de-at‏ ‎‡9 nds‏ ‎‡9 nl‏ ‎‡9 pl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a George Morris‏ ‎‡c chemist at University College London‏ ‎‡9 en‏
670 ‎‡a Author's A single system for the evaluation of purine and pyrimidine nucleosides and bases together with their analogues in biological fluids‏
670 ‎‡a Author's Accumulation of the anti-fungal diterpene sclareol by cell cultures of Salvia sclarea and Nicotiana glutinosa‏
670 ‎‡a Author's Allopurinol in renal failure and the tumour lysis syndrome‏
670 ‎‡a Author's Altered erythrocyte nucleotide patterns are characteristic of inherited disorders of purine or pyrimidine metabolism‏
670 ‎‡a Author's ATP formation from deoxyadenosine in human erythrocytes: evidence for a hitherto unidentified route involving adenine and S-adenosylhomocysteine hydrolase‏
670 ‎‡a Author's B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine‏
670 ‎‡a Author's B-lymphocytes, thymocytes and platelets accumulate high dATP levels in simulated ADA deficiency‏
670 ‎‡a Author's Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency‏
670 ‎‡a Author's Correlations between purine levels, clinical and immunological status in ADA deficiency‏
670 ‎‡a Author's dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: Significance for the immune response?‏
670 ‎‡a Author's Deoxy GTP accumulates in thymocytes, but not in T or B lymphocytes in simulated PNP deficiency‏
670 ‎‡a Author's EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes‏
670 ‎‡a Author's Erythrocyte GTP depletion in PNP deficiency presenting with haemolytic anaemia and hypouricaemia‏
670 ‎‡a Author's Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency‏
670 ‎‡a Author's Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency‏
670 ‎‡a Author's Metabolism of deoxynucleosides by lymphocytes in long-term culture deficient in different purine enzymes‏
670 ‎‡a Author's Optimised conditions for the routine HPLC separation of nucleotides in cell extracts‏
670 ‎‡a Author's Partial purification of farnesyl pyrophosphate: Drimenol cyclase and geranylgeranyl pyrophosphate: Sclareol cyclase, using cell culture as a source of material‏
670 ‎‡a Author's Prenatal exclusion of purine nucleoside phosphorylase deficiency‏
670 ‎‡a Author's Production of trans-β-farnesene by callus of Humulus lupulus‏
670 ‎‡a Author's Purine metabolites in uraemia‏
670 ‎‡a Author's Rapid determination of purine enzyme activity in intact and lysed cells using high-performance liquid chromatography with and without radiolabelled substrates‏
670 ‎‡a Author's Superoxide radicals, immunodeficiency and xanthine oxidase activity: man is not a mouse!‏
670 ‎‡a Author's The use and abuse of allopurinol in renal failure, the tumour lysis syndrome and HGPRT deficiency‏
670 ‎‡a Author's Urinary oxalate levels are not affected by dietary purine intake or allopurinol‏
670 ‎‡a Author's Use of a fundamental elution protocol for the development of reversed-phase high-performance liquid chromatography enabling rapid simultaneous determination of purines, pyrimidines and allied compounds commonly found in human biological fluids‏
670 ‎‡a Author's Use of biological fluids for the rapid diagnosis of potentially lethal inherited disorders of human purine and pyrimidine metabolism‏
919 ‎‡a metabolismofdeoxynucleosidesbylymphocytesinlongtermculturedeficientindifferentpurineenzymes‏ ‎‡A Metabolism of deoxynucleosides by lymphocytes in long-term culture deficient in different purine enzymes‏ ‎‡9 1‏
919 ‎‡a optimisedconditionsfortheroutinehplcseparationofnucleotidesincellextracts‏ ‎‡A Optimised conditions for the routine HPLC separation of nucleotides in cell extracts‏ ‎‡9 1‏
919 ‎‡a superoxideradicalsimmunodeficiencyandxanthineoxidaseactivitymanisnotamouse‏ ‎‡A Superoxide radicals, immunodeficiency and xanthine oxidase activity: man is not a mouse!‏ ‎‡9 1‏
919 ‎‡a useofafundamentalelutionprotocolforthedevelopmentofreversedphasehighperformanceliquidchromatographyenablingrapidsimultaneousdeterminationofpurinespyrimidinesandalliedcompoundscommonlyfoundinhumanbiologicalfluids‏ ‎‡A Use of a fundamental elution protocol for the development of reversed-phase high-performance liquid chromatography enabling rapid simultaneous determination of purines, pyrimidines and allied compounds commonly found in human biological fluids‏ ‎‡9 1‏
919 ‎‡a urinaryoxalatelevelsarenotaffectedbydietarypurineintakeorallopurinol‏ ‎‡A Urinary oxalate levels are not affected by dietary purine intake or allopurinol‏ ‎‡9 1‏
919 ‎‡a humanblymphocytesandthymocytesbutnotperipheralbloodmononuclearcellsaccumulatehighdatplevelsinconditionssimulatingadadeficiency‏ ‎‡A Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency‏ ‎‡9 1‏
919 ‎‡a deoxygtpaccumulatesinthymocytesbutnotintorblymphocytesinsimulatedpnpdeficiency‏ ‎‡A Deoxy GTP accumulates in thymocytes, but not in T or B lymphocytes in simulated PNP deficiency‏ ‎‡9 1‏
919 ‎‡a datpaccumulationandatpdepletioninplateletsinadenosinedeaminasedeficiencysignificancefortheimmuneresponse‏ ‎‡A dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: Significance for the immune response?‏ ‎‡9 1‏
919 ‎‡a heterogeneityofbiochemicalclinicalandimmunologicalparametersinseverecombinedimmunodeficiencyduetoadenosinedeaminasedeficiency‏ ‎‡A Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency‏ ‎‡9 1‏
919 ‎‡a purinemetabolitesinuraemia‏ ‎‡A Purine metabolites in uraemia‏ ‎‡9 1‏
919 ‎‡a erythrocytegtpdepletioninpnpdeficiencypresentingwithhaemolyticanaemiaandhypouricaemia‏ ‎‡A Erythrocyte GTP depletion in PNP deficiency presenting with haemolytic anaemia and hypouricaemia‏ ‎‡9 1‏
919 ‎‡a partialpurificationoffarnesylpyrophosphatedrimenolcyclaseandgeranylgeranylpyrophosphatesclareolcyclaseusingcellcultureasasourceofmaterial‏ ‎‡A Partial purification of farnesyl pyrophosphate: Drimenol cyclase and geranylgeranyl pyrophosphate: Sclareol cyclase, using cell culture as a source of material‏ ‎‡9 1‏
919 ‎‡a ehnaisapoorinhibitorofdeoxyadenosinecatabolisminculturedhumanlymphocytes‏ ‎‡A EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes‏ ‎‡9 1‏
919 ‎‡a correlationsbetweenpurinelevelsclinicalandimmunologicalstatusinadadeficiency‏ ‎‡A Correlations between purine levels, clinical and immunological status in ADA deficiency‏ ‎‡9 1‏
919 ‎‡a rapiddeterminationofpurineenzymeactivityinintactandlysedcellsusinghighperformanceliquidchromatographywithandwithoutradiolabelledsubstrates‏ ‎‡A Rapid determination of purine enzyme activity in intact and lysed cells using high-performance liquid chromatography with and without radiolabelled substrates‏ ‎‡9 1‏
919 ‎‡a useofbiologicalfluidsfortherapiddiagnosisofpotentiallylethalinheriteddisordersofhumanpurineandpyrimidinemetabolism‏ ‎‡A Use of biological fluids for the rapid diagnosis of potentially lethal inherited disorders of human purine and pyrimidine metabolism‏ ‎‡9 1‏
919 ‎‡a prenatalexclusionofpurinenucleosidephosphorylasedeficiency‏ ‎‡A Prenatal exclusion of purine nucleoside phosphorylase deficiency‏ ‎‡9 1‏
919 ‎‡a useandabuseofallopurinolinrenalfailurethetumourlysissyndromeandhgprtdeficiency‏ ‎‡A The use and abuse of allopurinol in renal failure, the tumour lysis syndrome and HGPRT deficiency‏ ‎‡9 1‏
919 ‎‡a centralnervoussystemdysfunctionanderythrocyteguanosinetriphosphatedepletioninpurinenucleosidephosphorylasedeficiency‏ ‎‡A Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency‏ ‎‡9 1‏
919 ‎‡a singlesystemfortheevaluationofpurineandpyrimidinenucleosidesandbasestogetherwiththeiranaloguesinbiologicalfluids‏ ‎‡A A single system for the evaluation of purine and pyrimidine nucleosides and bases together with their analogues in biological fluids‏ ‎‡9 1‏
919 ‎‡a accumulationoftheantifungalditerpenesclareolbycellculturesofsalviasclareaandnicotianaglutinosa‏ ‎‡A Accumulation of the anti-fungal diterpene sclareol by cell cultures of Salvia sclarea and Nicotiana glutinosa‏ ‎‡9 1‏
919 ‎‡a productionoftransβfarnesenebycallusofhumuluslupulus‏ ‎‡A Production of trans-β-farnesene by callus of Humulus lupulus‏ ‎‡9 1‏
919 ‎‡a blymphocytesthymocytesandplateletsaccumulatehighdatplevelsinsimulatedadadeficiency‏ ‎‡A B-lymphocytes, thymocytes and platelets accumulate high dATP levels in simulated ADA deficiency‏ ‎‡9 1‏
919 ‎‡a bcellsaswellastcellsformdeoxynucleotidesfromeitherdeoxyadenosineordeoxyguanosine‏ ‎‡A B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine‏ ‎‡9 1‏
919 ‎‡a atpformationfromdeoxyadenosineinhumanerythrocytesevidenceforahithertounidentifiedrouteinvolvingadenineandsadenosylhomocysteinehydrolase‏ ‎‡A ATP formation from deoxyadenosine in human erythrocytes: evidence for a hitherto unidentified route involving adenine and S-adenosylhomocysteine hydrolase‏ ‎‡9 1‏
919 ‎‡a alterederythrocytenucleotidepatternsarecharacteristicofinheriteddisordersofpurineorpyrimidinemetabolism‏ ‎‡A Altered erythrocyte nucleotide patterns are characteristic of inherited disorders of purine or pyrimidine metabolism‏ ‎‡9 1‏
919 ‎‡a allopurinolinrenalfailureandthetumourlysissyndrome‏ ‎‡A Allopurinol in renal failure and the tumour lysis syndrome‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 NTA|131858025‏
996 ‎‡2 ISNI|0000000396433873‏
996 ‎‡2 SUDOC|255111258‏
996 ‎‡2 NII|DA09687264‏
996 ‎‡2 ISNI|0000000115598939‏
996 ‎‡2 DNB|1180640330‏
996 ‎‡2 CAOONL|ncf11198714‏
996 ‎‡2 SUDOC|194059294‏
996 ‎‡2 DNB|117126285X‏
996 ‎‡2 ISNI|0000000032318364‏
996 ‎‡2 LC|n 81123104‏
996 ‎‡2 RERO|A018685992‏
996 ‎‡2 LC|no2014012832‏
996 ‎‡2 J9U|987007351786005171‏
996 ‎‡2 LC|no2016087360‏
996 ‎‡2 RERO|A018685994‏
996 ‎‡2 LC|nr2001023740‏
996 ‎‡2 LC|n 84150533‏
996 ‎‡2 DNB|1048547906‏
996 ‎‡2 CAOONL|ncf11559786‏
996 ‎‡2 LC|nb2017003450‏
996 ‎‡2 SUDOC|083182543‏
996 ‎‡2 LC|n 85113431‏
996 ‎‡2 ISNI|0000000001391585‏
996 ‎‡2 LC|no2003019768‏
996 ‎‡2 ISNI|0000000067054231‏
996 ‎‡2 LC|no2023068890‏
996 ‎‡2 LC|no2007020326‏
996 ‎‡2 LC|no2012134785‏
996 ‎‡2 BIBSYS|90556294‏
996 ‎‡2 PLWABN|9810596039505606‏
996 ‎‡2 N6I|vtls000045354‏
996 ‎‡2 NKC|xx0227104‏
996 ‎‡2 RERO|A003611012‏
996 ‎‡2 RERO|A003611011‏
996 ‎‡2 BNF|17093141‏
996 ‎‡2 NUKAT|n 99051796‏
996 ‎‡2 LC|no2022050592‏
996 ‎‡2 LC|no2018114220‏
996 ‎‡2 LC|n 82225996‏
996 ‎‡2 NTA|101178832‏
996 ‎‡2 LC|no2022044002‏
996 ‎‡2 CAOONL|ncf10336366‏
996 ‎‡2 DNB|1129813975‏
996 ‎‡2 NTA|068208251‏
996 ‎‡2 RERO|A023467336‏
996 ‎‡2 LC|nr 93027046‏
996 ‎‡2 J9U|987007279649105171‏
996 ‎‡2 LC|no2005029229‏
996 ‎‡2 JPG|500094251‏
996 ‎‡2 BIBSYS|90134051‏
996 ‎‡2 LC|no2021149509‏
996 ‎‡2 NII|DA12083956‏
996 ‎‡2 ISNI|0000000115774808‏
996 ‎‡2 LC|n 82113976‏
996 ‎‡2 LIH|LNB:C_n__q__x_;=C_k_‏
996 ‎‡2 SUDOC|122064186‏
996 ‎‡2 JPG|500016166‏
996 ‎‡2 SUDOC|073679291‏
996 ‎‡2 RERO|A006402125‏
996 ‎‡2 ISNI|0000000074029560‏
996 ‎‡2 NTA|069682739‏
996 ‎‡2 ISNI|0000000501721405‏
996 ‎‡2 NII|DA17084639‏
996 ‎‡2 JPG|500167857‏
996 ‎‡2 LC|n 79016564‏
996 ‎‡2 RERO|A003611038‏
996 ‎‡2 LC|n 79044070‏
996 ‎‡2 ISNI|0000000430470687‏
996 ‎‡2 LC|n 2008042142‏
996 ‎‡2 NLA|000035403222‏
996 ‎‡2 NUKAT|n 2002067308‏
996 ‎‡2 J9U|987007389175205171‏
996 ‎‡2 PLWABN|9811287052105606‏
996 ‎‡2 SUDOC|103461051‏
996 ‎‡2 LC|n 99830337‏
996 ‎‡2 NLA|000035920857‏
996 ‎‡2 RERO|A024760792‏
996 ‎‡2 ISNI|0000000048053874‏
996 ‎‡2 ISNI|0000000035928846‏
996 ‎‡2 BIBSYS|90192927‏
996 ‎‡2 ISNI|0000000395298374‏
996 ‎‡2 NTA|214069001‏
996 ‎‡2 ISNI|0000000040987111‏
996 ‎‡2 LNB|LNC10-000038769‏
996 ‎‡2 LC|n 2007161707‏
996 ‎‡2 LC|n 93026228‏
996 ‎‡2 DNB|118785001‏
996 ‎‡2 NUKAT|nx2022805670‏
996 ‎‡2 BIBSYS|7006997‏
996 ‎‡2 BIBSYS|90560103‏
996 ‎‡2 BAV|495_108848‏
996 ‎‡2 NII|DA0087989X‏
996 ‎‡2 NLA|000035779429‏
996 ‎‡2 LC|no2011123665‏
996 ‎‡2 NKC|xx0080576‏
996 ‎‡2 SUDOC|200389637‏
996 ‎‡2 J9U|987007386115205171‏
996 ‎‡2 NUKAT|n 2020209545‏
996 ‎‡2 ISNI|0000000117079796‏
996 ‎‡2 NTA|304299472‏
996 ‎‡2 RERO|A000116164‏
996 ‎‡2 DNB|1057557358‏
996 ‎‡2 LC|n 2001045575‏
996 ‎‡2 LC|no2006110971‏
996 ‎‡2 J9U|987007354415005171‏
996 ‎‡2 ISNI|000000005718354X‏
996 ‎‡2 LC|n 2018058356‏
996 ‎‡2 RERO|A003611039‏
996 ‎‡2 SUDOC|25781213X‏
996 ‎‡2 LC|n 84119573‏
996 ‎‡2 NTA|07274653X‏
996 ‎‡2 ISNI|0000000074812547‏
996 ‎‡2 ISNI|0000000048782874‏
996 ‎‡2 LC|n 91040919‏
996 ‎‡2 ISNI|0000000036657021‏
996 ‎‡2 RERO|A013544057‏
996 ‎‡2 BNF|14770479‏
996 ‎‡2 NII|DA1043128X‏
996 ‎‡2 BNF|14603821‏
996 ‎‡2 J9U|987007278672305171‏
996 ‎‡2 J9U|987007386916505171‏
996 ‎‡2 NTA|411937472‏
996 ‎‡2 BNF|12380225‏
996 ‎‡2 J9U|987007424963305171‏
996 ‎‡2 LC|n 96118643‏
996 ‎‡2 SUDOC|233225129‏
996 ‎‡2 BIBSYS|90348798‏
996 ‎‡2 CAOONL|ncf10726545‏
996 ‎‡2 CAOONL|ncf11294518‏
996 ‎‡2 LC|n 2010023993‏
996 ‎‡2 LC|n 98035098‏
996 ‎‡2 ISNI|0000000072631566‏
996 ‎‡2 CAOONL|ncf11294517‏
996 ‎‡2 NLA|000035363420‏
996 ‎‡2 ISNI|000000002826675X‏
996 ‎‡2 LC|n 94090690‏
996 ‎‡2 N6I|vtls001405647‏
996 ‎‡2 ISNI|0000000082784590‏
996 ‎‡2 NUKAT|n 01031580‏
996 ‎‡2 J9U|987007314985405171‏
996 ‎‡2 LC|no2003015844‏
996 ‎‡2 ISNI|0000000397278705‏
996 ‎‡2 NDL|00524570‏
996 ‎‡2 NTA|074835238‏
996 ‎‡2 ISNI|0000000084224327‏
996 ‎‡2 J9U|987007270530205171‏
996 ‎‡2 NYNYRILM|224210‏
996 ‎‡2 ISNI|0000000048380963‏
996 ‎‡2 LC|no2008121648‏
996 ‎‡2 RERO|A003414871‏
996 ‎‡2 N6I|vtls000290544‏
996 ‎‡2 LC|n 90683402‏
996 ‎‡2 LC|nr2001004679‏
996 ‎‡2 LC|no2022144380‏
996 ‎‡2 DNB|1055642668‏
996 ‎‡2 LC|n 79100397‏
996 ‎‡2 NTA|156334569‏
996 ‎‡2 ISNI|0000000035142464‏
996 ‎‡2 SUDOC|15817237X‏
996 ‎‡2 BNF|11916921‏
996 ‎‡2 DNB|124784437‏
996 ‎‡2 JPG|500167856‏
996 ‎‡2 NLA|000035097687‏
996 ‎‡2 LC|no2010168977‏
996 ‎‡2 JPG|500015636‏
996 ‎‡2 SUDOC|085945390‏
996 ‎‡2 LC|n 2014032451‏
996 ‎‡2 LC|nr 93007447‏
996 ‎‡2 LC|n 88601062‏
996 ‎‡2 NKC|utb2015890697‏
996 ‎‡2 ISNI|0000000084760111‏
996 ‎‡2 RERO|A006100662‏
996 ‎‡2 SUDOC|113288921‏
996 ‎‡2 ISNI|0000000045207401‏
996 ‎‡2 DNB|12685467X‏
996 ‎‡2 SUDOC|060890592‏
996 ‎‡2 ISNI|0000000452803200‏
996 ‎‡2 LC|no2013050190‏
996 ‎‡2 ISNI|0000000110776775‏
996 ‎‡2 N6I|vtls001396854‏
996 ‎‡2 LC|n 88655695‏
996 ‎‡2 LC|n 90648714‏
996 ‎‡2 SUDOC|030159180‏
996 ‎‡2 BAV|495_163690‏
996 ‎‡2 J9U|987007461653005171‏
996 ‎‡2 NUKAT|n 2003060599‏
996 ‎‡2 ISNI|0000000403343105‏
996 ‎‡2 J9U|987007332586905171‏
996 ‎‡2 LC|n 89612207‏
996 ‎‡2 LC|n 96116688‏
996 ‎‡2 BLBNB|001468314‏
996 ‎‡2 DNB|1052504833‏
996 ‎‡2 ISNI|0000000024112868‏
996 ‎‡2 SELIBR|388093‏
996 ‎‡2 NUKAT|n 2008147551‏
996 ‎‡2 LC|n 2003074218‏
996 ‎‡2 LC|n 2011065316‏
996 ‎‡2 ISNI|000000008453072X‏
996 ‎‡2 LC|n 98102473‏
996 ‎‡2 ISNI|000000003347879X‏
996 ‎‡2 ISNI|000000008353469X‏
996 ‎‡2 LC|no2011060367‏
996 ‎‡2 CAOONL|ncf10080562‏
996 ‎‡2 CAOONL|ncf11589326‏
996 ‎‡2 DNB|1055237607‏
996 ‎‡2 J9U|987007452809905171‏
996 ‎‡2 LC|n 2022004423‏
996 ‎‡2 ISNI|0000000082484213‏
996 ‎‡2 NKC|jn20020717777‏
996 ‎‡2 LC|nb2013025182‏
996 ‎‡2 DNB|1266464042‏
996 ‎‡2 LC|no 90005592‏
996 ‎‡2 RERO|A024542998‏
996 ‎‡2 LC|n 85135638‏
996 ‎‡2 LNB|LNC10-000079061‏
996 ‎‡2 NUKAT|n 2016167987‏
996 ‎‡2 NUKAT|n 2011074447‏
996 ‎‡2 BIBSYS|90575294‏
996 ‎‡2 SUDOC|270583289‏
996 ‎‡2 NTA|069758476‏
996 ‎‡2 BLBNB|000489284‏
996 ‎‡2 NTA|436050870‏
996 ‎‡2 ISNI|0000000494106024‏
996 ‎‡2 LC|n 82004202‏
996 ‎‡2 SUDOC|270826556‏
996 ‎‡2 LC|nb2017021452‏
996 ‎‡2 LIH|LNB:C_i_U_g_;=B4‏
996 ‎‡2 DNB|142038164‏
996 ‎‡2 NUKAT|n 2013145443‏
996 ‎‡2 LC|n 81032919‏
996 ‎‡2 RERO|A023300506‏
996 ‎‡2 CAOONL|ncf10375032‏
996 ‎‡2 ISNI|0000000119117688‏
996 ‎‡2 NUKAT|n 2013168818‏
996 ‎‡2 BIBSYS|4057290‏
996 ‎‡2 LC|n 95800458‏
996 ‎‡2 NUKAT|n 01036984‏
996 ‎‡2 NUKAT|n 01024780‏
996 ‎‡2 LC|n 82269865‏
996 ‎‡2 NII|DA10143048‏
996 ‎‡2 SUDOC|027039161‏
996 ‎‡2 SUDOC|275648303‏
996 ‎‡2 NUKAT|n 2017160374‏
996 ‎‡2 BIBSYS|90510010‏
996 ‎‡2 JPG|500003822‏
996 ‎‡2 ISNI|0000000067789246‏
996 ‎‡2 LC|n 84181681‏
996 ‎‡2 ISNI|0000000023441299‏
996 ‎‡2 CAOONL|ncf10293984‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a George, Morris.‏ ‎‡2 NUKAT|n 2016151001‏ ‎‡3 exact name‏